<?xml version="1.0" encoding="UTF-8"?>
<ref id="B125-vaccines-07-00053">
 <label>125.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Simoes</surname>
    <given-names>E.A.</given-names>
   </name>
   <name>
    <surname>Groothuis</surname>
    <given-names>J.R.</given-names>
   </name>
   <name>
    <surname>Carbonell-Estrany</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Rieger</surname>
    <given-names>C.H.</given-names>
   </name>
   <name>
    <surname>Mitchell</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Fredrick</surname>
    <given-names>L.M.</given-names>
   </name>
   <name>
    <surname>Kimpen</surname>
    <given-names>J.L.</given-names>
   </name>
   <collab>Palivizumab Long-Term Respiratory Outcomes Study Group</collab>
  </person-group>
  <article-title>Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing</article-title>
  <source>J. Pediatr.</source>
  <year>2007</year>
  <volume>151</volume>
  <fpage>34</fpage>
  <lpage>42</lpage>
  <pub-id pub-id-type="doi">10.1016/j.jpeds.2007.02.032</pub-id>
  <?supplied-pmid 17586188?>
  <pub-id pub-id-type="pmid">17586188</pub-id>
 </element-citation>
</ref>
